Current price is more than the intrinsic value

Intrinsic value

Stock has been generating better return on equity than bank FD

ROE vs FD rates

Stock doesn't offer attractive dividend returns

Dividend Returns

Good time to consider, as stock is not in overbought zone

Entry point

Stock not in ASM/GSM lists and not a lot of promoter holding is pledged

No Red Flags

Today’ Pick: Poly Medicure (₹953.9): BUY

Sun Pharma Advanced Research Company Ltd, Esab India Ltd, Rites Ltd and Poly Medicure Ltd are among the other gainers in the BSE’s ‘A’ group today, 29 September 2022.

Century Enka Ltd leads gainers in ‘A’ group

A mid-cap company with a market worth of Rs. 8,626.24 crore, Poly Medicure Ltd. operates in the hospital industry

Multibagger stock sets record date for dividend, promoter holding up 8.68% QoQ

Poly Medicure Ltd clocked volume of 11202 shares by 10:47 IST on BSE, a 8.07 times surge over two-week average daily volume of 1388 shares

Volumes soar at Poly Medicure Ltd counter

Poly Medicure Q4 Review - Strong Domestic Growth: ICICI Securities

Poly Medicure Standalone March 2022 Net Sales at Rs 244.44 crore, up 20.71% Y-o-Y

Lux Industries Ltd, Cerebra Integrated Technologies Ltd, Birla Corporation Ltd and Poly Medicure Ltd are among the other losers in the BSE’s ‘A’ group today, 04 April 2022.

Team Lease Services Ltd leads losers in ‘A’ group

Poly Medicure Consolidated December 2021 Net Sales At Rs 230.28 Crore, Up 13.15% Y-o-Y

In our new show "Inside Out", we focus on individual stocks with an in-depth analysis and also tell you about the key risks going forward. In this episode we take deep into the stock of MTAR Technologies and also discuss all about Indian Medical Device Industry and the stock of Poly Medicure from that space.

#CNBCTV18 #BusinessNews #ShareMarketToday #Nifty #Sensex #MTARTechnologies #IndianMedicalDeviceIndustry #PolyMedicure

CNBC-TV18 is India's No.1 Business medium and the undisputed leader in business news. The channel's benchmark coverage extends from corporate news, financial markets coverage, expert perspective on investing and management to industry verticals and beyond. CNBC-TV18 has been constantly innovating with new genres of programming that helps make business more relevant to different constituencies across India. India's most able business audience consumes CNBC-TV18 for their information & investing needs. This audience is highly diversified at one level comprising of key groups such as business leaders, professionals, retail investors, brokers and traders, intermediaries, self-employed professionals, High Net Worth individuals, students and even homemakers but shares a distinct commonality in terms of their spirit of enterprise.

For latest news and updates visit our Website: https://bit.ly/2YbpXBM
Subscribe to our Channel: https://www.youtube.com/user/CNBCTV18
Like us on Facebook: https://www.facebook.com/cnbctv18india/
Follow us on Twitter: https://twitter.com/CNBCTV18News

Focusing On MTAR Tech's Biz & Poly Medicure From Indian Medical Device Industry | Inside Out

In our segment of Swotlight, we focus on the Indian medical device industry which will be critical from here on. From the industry, we focus on the company called Poly Medicure. Here is a business update from the industry as well as the company

#CNBCTV18 #BusinessNews #ShareMarketToday #Nifty #Sensex #IndianMedicalDeviceIndustry #PolyMedicure

CNBC-TV18 is India's No.1 Business medium and the undisputed leader in business news. The channel's benchmark coverage extends from corporate news, financial markets coverage, expert perspective on investing and management to industry verticals and beyond. CNBC-TV18 has been constantly innovating with new genres of programming that helps make business more relevant to different constituencies across India. India's most able business audience consumes CNBC-TV18 for their information & investing needs. This audience is highly diversified at one level comprising of key groups such as business leaders, professionals, retail investors, brokers and traders, intermediaries, self-employed professionals, High Net Worth individuals, students and even homemakers but shares a distinct commonality in terms of their spirit of enterprise.

For latest news and updates visit our Website: https://bit.ly/2YbpXBM
Subscribe to our Channel: https://www.youtube.com/user/CNBCTV18
Like us on Facebook: https://www.facebook.com/cnbctv18india/
Follow us on Twitter: https://twitter.com/CNBCTV18News

Focusing On India's Medical Device Industry & Poly Medicure's Stock | Inside Out | CNBC-TV18

Deep Dive Into MTAR Tech | All About Indian Medical Device Industry & Poly Medicure | Inside Out

Poly Medicure Limited is engaged in the manufacturing and sale of medical devices.

Poly Medicure Ltd

Poly Medicure Ltd

Intrinsic value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

Today’ Pick: Poly Medicure (₹953.9): BUY

Century Enka Ltd leads gainers in ‘A’ group

Multibagger stock sets record date for dividend, promoter holding up 8.68% QoQ

Volumes soar at Poly Medicure Ltd counter

Poly Medicure Q4 Review - Strong Domestic Growth: ICICI Securities

Poly Medicure Standalone March 2022 Net Sales at Rs 244.44 crore, up 20.71% Y-o-Y

Team Lease Services Ltd leads losers in ‘A’ group

Poly Medicure Ltd

Intrinsic valueIntrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD ratesFixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend ReturnsA dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry pointHigh demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

Today’ Pick: Poly Medicure (₹953.9): BUY

Century Enka Ltd leads gainers in ‘A’ group

Multibagger stock sets record date for dividend, promoter holding up 8.68% QoQ

Volumes soar at Poly Medicure Ltd counter

Poly Medicure Q4 Review - Strong Domestic Growth: ICICI Securities

Poly Medicure Standalone March 2022 Net Sales at Rs 244.44 crore, up 20.71% Y-o-Y

Team Lease Services Ltd leads losers in ‘A’ group

Intrinsic value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock